AVTR:NYE-Avantor Inc (USD)

COMMON STOCK | Specialty Chemicals | NYE

Last Closing Price

USD 31.22

Change

0.00 (0.00)%

Market Cap

USD 18.99B

Volume

4.06M

Avg Analyst Target

USD 41.91 (+34.24%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


Avantor Inc (AVTR) Stock Analysis:
Based on the Avantor Inc stock forecasts from 9 analysts, the average analyst target price for Avantor Inc is USD 41.91 over the next 12 months. Avantor Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Avantor Inc is Neutral, which is based on 6 positive signals and 6 negative signals. At the last closing, Avantor Inc’s stock price was USD 31.22. Avantor Inc’s stock price has changed by +3.89% over the past week, -0.32% over the past month and +0.16% over the last year.

About

Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-05-21 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
LIN Linde plc

N/A

USD156.20B 40.03 16.57
SHW The Sherwin-Williams Company

N/A

USD67.47B 37.66 25.59
APD Air Products and Chemicals Inc

N/A

USD52.69B 23.66 13.69
ECL Ecolab Inc

N/A

USD45.03B 41.04 21.76
LYB LyondellBasell Industries N.V

N/A

USD35.72B 6.21 5.18
IFF International Flavors & Fragra..

N/A

USD32.88B 59.34 20.01
DD DuPont de Nemours Inc

N/A

USD32.71B 21.48 10.52
PPG PPG Industries Inc

N/A

USD28.97B 27.17 16.84
ALB Albemarle Corporation

N/A

USD27.69B 98.85 48.33
WLK Westlake Chemical Corporation

N/A

USD16.82B 8.41 4.98

ETFs Containing AVTR

Symbol Name Weight Mer Price(Change) Market Cap
BSJO Invesco BulletShares 2024.. 0.00 % 0.42 %

N/A

USD0.49B
FPX First Trust US Equity Opp.. 0.00 % 0.57 %

N/A

USD1.09B
FXH First Trust Health Care A.. 0.00 % 0.61 %

N/A

USD1.41B
HYDW DBX ETF Trust - Xtrackers.. 0.00 % 0.20 %

N/A

USD1.46B
SFYX Tidal ETF Trust - SoFi Ne.. 0.00 % 0.00 %

N/A

USD0.05B
FPX:LSE First Trust Global Funds .. 0.00 % 0.65 %

N/A

USD0.01B
XSDR:LSE Xtrackers - Stoxx Europe .. 0.00 % 0.30 %

N/A

USD0.11B
FPXU:PA First Trust US Equity Opp.. 0.00 % 0.65 %

N/A

USD0.01B
BMED BlackRock Future Health E.. 0.00 % 0.85 %

N/A

N/A
VNMC Natixis ETF Trust II - Na.. 0.00 % 0.85 %

N/A

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -25.91% 25% F 22% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -25.91% 25% F 21% F
Trailing 12 Months  
Capital Gain 0.16% 67% D+ 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.16% 62% D- 73% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 36.30% 93% A 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 36.30% 91% A- 91% A-
Risk Return Profile  
Volatility (Standard Deviation) 41.37% 34% F 25% F
Risk Adjusted Return 87.74% 93% A 91% A-
Market Capitalization 18.99B 80% B- 88% B+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 35.03 25% F 16% F
Price/Book Ratio 5.49 12% F 14% F
Price / Cash Flow Ratio 19.92 30% F 17% F
EV/EBITDA 18.33 17% F 23% F
Management Effectiveness  
Return on Equity 16.72% 64% D 70% C-
Return on Invested Capital 12.27% 66% D 74% C
Return on Assets 5.92% 59% F 76% C
Debt to Equity Ratio 166.26% 24% F 21% F
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio 2.59 58% F 42% F
Short Percent 3.28% 23% F 52% F
Beta 1.53 29% F 19% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Discussions

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.